Wuhan Mingde Bio-Technology Co., Ltd.
Pro Forma Review Report for 2025-March 2026
BDO Shu Lun Pan [2026] No. ZE10738
Review Report and Pro Forma Financial Statements
(January 1, 2025 to March 31, 2026)
Table of Contents
-
Review Report
-
Pro Forma Financial Statements
Pro Forma Consolidated Balance Sheet
Pro Forma Consolidated Income Statement
Notes to Pro Forma Consolidated Financial Statements
[Image: BDO Logo]
Review Report
To the Shareholders of Wuhan Mingde Bio-Technology Co., Ltd.:
We have reviewed the accompanying pro forma consolidated financial statements of Wuhan Mingde Bio-Technology Co., Ltd. (hereinafter referred to as "Mingde Bio"), including the pro forma consolidated balance sheets as of March 31, 2026 and December 31, 2025, the pro forma consolidated income statements for the three months ended March 31, 2026 and the year 2025, and the notes to the pro forma consolidated financial statements. The preparation of these pro forma consolidated financial statements in accordance with the basis of preparation described in Note III is the responsibility of Mingde Bio's management. Our responsibility is to issue a review report on these pro forma consolidated financial statements based on our review work.
We conducted our review in accordance with the "Chinese Certified Public Accountant Review Standard No. 2101 — Review of Financial Statements." This standard requires us to plan and perform the review to obtain limited assurance as to whether the pro forma consolidated financial statements are free from material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data, providing a lower level of assurance than an audit. We have not performed an audit and, accordingly, do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the above pro forma consolidated financial statements have not been prepared, in all material respects, in accordance with the basis of preparation described in Note III of the notes to the pro forma consolidated financial statements.
We draw the attention of the users of the pro forma consolidated financial statements to the description of the basis of preparation in Note III. This review report is provided solely for the purpose of Mingde Bio's current major asset restructuring and must not be used for any other purpose.
(This page has no text)
BDO China Shu Lun Pan Certified Public Accountants LLP
Certified Public Accountant: Li Hongyong [blank]
Certified Public Accountant: Liu Lu [blank]
Shanghai, China
July 31, 2026
(Unless otherwise specified, amounts are in RMB)